EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review

Suvitesh Luthra iD, Laura Viola iD, Manoraj Navaratnarajah, David Thirukumaran, Theodore Velissaris

Journal of Clinical Medicine · 24.12.2024 · 14 (1) · 23

DOI: 10.3390/jcm14010023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.12.2024. Verfasst von Suvitesh Luthra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wessex Cardiothoracic Centre, Division of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Perioperative dysglycaemia in cardiac surgery is associated with poor outcomes. Glycaemic variability rather than glucose levels is a predictor of the length of an ICU stay, a rise in creatinine and acute kidney injury after cardiac surgery. Glycated haemoglobin (HbA1C) values correspond closely to average blood glucose levels and cut-off values can be used to define a diabetic and pre-diabetic status. These have been correlated with perioperative events.

Methods

In this narrative review, MEDLINE (via PubMed) and the Cochrane Library were used to search for the effects of different preoperative HbA1C levels on the postoperative outcomes after cardiac surgery. HbA1C values correspond closely with average blood glucose levels and cut-off values can be used to define a diabetic and pre-diabetic status; these have been correlated with perioperative events. This narrative review discusses the role of HbA1C in cardiac surgery.

Discussion

The scientific data show controversial results: some systematic reviews and randomised control trials demonstrated that a high level of HbA1C seems to be an indicator for postoperative complications in cardiac surgery; other studies dissented and reported that mortality and morbidity cannot be directly attributed to HbA1c levels.

Conclusions

The scientific community seems to be in general agreement that high levels of HbA1C are prognostic markers of adverse outcomes post cardiac surgery, but it has also been proved that there could be multiple underlying factors contributing to them.

Schlagwörter

Stichwörter der Autor:innen

HbA1Ccardiac surgeryclinical outcomesdiabetesglycated haemoglobin

Autor:innen und Institutionen

  • Wessex Cardiothoracic Centre, Division of Cardiac Surgery, University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK.
  • Academic Unit of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton SO17 1BJ, UK.

ORCID-Profile: Suvitesh Luthra, Laura Viola

Zitieren

APA

Luthra, S., Viola, L., Navaratnarajah, M., Thirukumaran, D., & Velissaris, T. (2024). Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review. Journal of Clinical Medicine, 14(1), 23. https://doi.org/10.3390/jcm14010023

Vancouver

Luthra S, Viola L, Navaratnarajah M, Thirukumaran D, Velissaris T. Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review. Journal of Clinical Medicine. 2024;14(1):23. doi:10.3390/jcm14010023

BibTeX
@article{Luthra2024,
  author = {Luthra, Suvitesh and Viola, Laura and Navaratnarajah, Manoraj and Thirukumaran, David and Velissaris, Theodore},
  title = {Glycated Haemoglobin (HbA1C) in Cardiac Surgery: A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {23},
  doi = {10.3390/jcm14010023}
}
Kostenlos starten →